The discussion of biotech was interesting. It made clear that Y Combinator is <i>replicating the biotech model of mass production of innovation.</i><p>Paul said (more or less) that the risk investing in Biotech was in some ways lower (because it's easier to identify the 20 leading scientists from whom the next wonder-discovery will emerge). I think this correct, but the comparison between that and what YC does is misguided.<p>Those leading scientists are like the companies who've <i>already been through YC,</i> presented on a platter for the big money to get at.<p>So what's the YC equivalent? Paul said it himself - grad school.<p>For Biotech, a PhD program is the way to mass-produce seed-funded innovation. You give someone a few years, let them attack a problem and generate data. The best PhDs coming out get labs and professorships (equivalent to venture funding worth $1-$2 million), etc.<p>Hacking is not science. Therefore a seed-funding model that works for science does not work well for software innovation. YC is the replacement - it's your PhD in software innovation. People go in, work with mentors (I meet my PhD supervisor once a week, and regularly hear talks from the best in the field, just like YC founders). The best innovators come out and get funded for $1-$2 million and hopefully go on.